This pathogen is the third most frequently isolated nontuberculous mycobacteria seen in the United States. Here is a review of how it presents and treatment options.
Subramanya Shyam Ganti, MD, MBBS
Advertisement
Ganti is a pulmonary disease specialist in Harlan, Kentucky, and an associate program director at the Appalachian Regional Healthcare internal medicine residency program.
Articles by Subramanya Shyam Ganti, MD, MBBS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
2
Misdiagnosis Common in Skin Infections Due to Overlapping Noninfectious Conditions
3
Cefiderocol is Noninferior, But not "Game-Changer," for Gram-negative Bloodstream Infections
4
As NDM-CRE Infections Rise Significantly, Diagnostic Access Emerges as Weak Link
5
